Clinical Trial Update: Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial compared two regimens of liposomal doxorubicin in women with metastatic breast cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED